IshidaTHijiokaHKumeKMiyawakiANakamuraN.Notch signaling induces EMT in OSCC cell lines in a hypoxic environment. Oncol Lett2013;
6:1201–6
2.
LohavanichbutrPHouckJDoodyDRWangPMendezEFutranNUptonMPHolsingerFCSchwartzSMChenC.Gene expression in uninvolved oral mucosa of OSCC patients facilitates identification of markers predictive of OSCC outcomes. 2012;
7:e46575
3.
CosteaDTsinkalovskyOVintermyrOJohannessenAMackenzieI.Cancer stem cells–new and potentially important targets for the therapy of oral squamous cell carcinoma. Oral Dis2006;
12:443–54
4.
BaillieRTanSTItinteangT.Cancer stem cells in oral cavity squamous cell carcinoma: a review. Front Oncol2017;
7:112
5.
YuCCHuFWYuCHChouMY.Targeting CD133 in the enhancement of chemosensitivity in oral squamous cell carcinoma-derived side population cancer stem cells. Head Neck2016;
38:E231–E8.
6.
GhuwalewalaSGhatakDDasPDeySSarkarSAlamNPandaCKRoychoudhuryS.CD44highCD24low molecular signature determines the cancer stem cell and EMT phenotype in oral squamous cell carcinoma. Stem Cell Res2016;
16:405–17
7.
VegforsJPeterssonSKovacsAPolyakKEnerbäckC.The expression of psoriasin (S100A7) and CD24 is linked and related to the differentiation of mammary epithelial cells. PloS One2012;
7:e53119
8.
MuppalaSMudduluruGLeupoldJHBuergyDSleemanJPAllgayerH.CD24 induces expression of the oncomir miR-21 via SRC, and CD24 and SRC are both post-transcriptionally downregulated by the tumor suppressor miR-34a. PloS One2013;
8:e59563
9.
PrinceMSivanandanRKaczorowskiAWolfGKaplanMDalerbaPWeissmanIClarkeMAillesL.Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Pnas2007;
104:973–8
10.
SarkarAHochedlingerK.The sox family of transcription factors: versatile regulators of stem and progenitor cell fate. Cell Stem Cell2013;
12:15–30
11.
LiuKLinBZhaoMYangXChenMGaoALiuFQueJLanX.The multiple roles for Sox2 in stem cell maintenance and tumorigenesis. Cell Signal2013;
25:1264–71
12.
BassAJWatanabeHMermelCHYuSPernerSVerhaakRGKimSYWardwellLTamayoP.Gat-Viks I. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet2009;
41:1238–42
13.
ZhangJChangDYMercado-UribeILiuJ.Sex-determining region Y-box 2 expression predicts poor prognosis in human ovarian carcinoma. Hum Pathol2012;
43:1405–12
14.
TaHTDassCRChoongPFDunstanDE.Osteosarcoma treatment: state of the art. Cancer Metastasis Rev2009;
28:247–63
15.
Basu-RoyUBasilicoCMansukhaniA.Perspectives on cancer stem cells in osteosarcoma. Cancer Lett2013;
338:158–67
16.
Basu-RoyUSeoERamanathapuramLRappTBPerryJAOrkinSHMansukhaniABasilicoC.Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas. Oncogene2012;
31:2270–82
17.
Basu-RoyUBayinNSRattanakornKHanEPlacantonakisDGMansukhaniABasilicoC.Sox2 antagonizes the hippo pathway to maintain stemness in cancer cells. Nat Commun2015;
6:6411
18.
BoumahdiSDriessensGLapougeGRoriveSNassarDLe MercierMDelatteBCaauweALenglezSNkusiE.SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma. Nature2014;
511:246–50
19.
WuQZhangLSuPLeiXLiuXWangHLuLBaiYXiongTLiDZhuZDuanEJiangEFengSHanMXuYWangFZhouJ.MSX2 mediates entry of human pluripotent stem cells into mesendoderm by simultaneously suppressing SOX2 and activating NODAL signaling. Cell Res2015;
25:1314–32
20.
YinYXieC-MLiHTanMChenGSchiffRXiongXSunY.The FBXW2–MSX2–SOX2 axis regulates stem cell property and drug resistance of cancer cells. Proc Natl Acad Sci USA2019;
116:20528–38
21.
BellJRNoveenALiuYHMaLDobiasSKunduRLuoWXiaYLusisAJSneadML.
Genomic structure, chromosomal location, and evolution of the mouse hox 8 gene. Genomics1993;
17:800
22.
DavidsonD.The function and evolution of msx genes: pointers and paradoxes. Trends Genet1995;
11:405–11
23.
MacKenzieAFergusonMWSharpePT.Expression patterns of the homeobox gene, hox-8, in the mouse embryo suggest a role in specifying tooth initiation and shape. Development (Cambridge, England)1992;
115:403–20
NewberryEPLatifiTBattaileJTTowlerDA.Structure-function analysis of Msx2-mediated transcriptional suppression. Biochemistry1997;
36:10451–62
26.
SatokataIMaLOhshimaHBeiMWooINishizawaKMaedaTTakanoYUchiyamaMHeaneySPetersHTangZMaxsonRMaasR.Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat Genet2000;
24:391–5
27.
Garcia-MiñaurSMavrogiannisLARannan-EliyaSVHendryMAListonWAPorteousMEWilkieAO.Parietal foramina with cleidocranial dysplasia is caused by mutation in MSX2. Eur J Hum Genet2003;
11:892–5
28.
WuytsWReardonWPreisSHomfrayTRasore-QuartinoAChristiansHWillemsPJ,
Van Hul W. Identification of mutations in the MSX2 homeobox gene in families affected with foramina parietalia permagna. Hum Mol Genet2000;
9:1251–5
29.
di BariMGGinsburgEPlantJStrizziLSalomonDSVonderhaarBK.Msx2 induces epithelial-mesenchymal transition in mouse mammary epithelial cells through upregulation of cripto-1. J Cell Physiol2009;
219:659–66
30.
FriedmannYDanielCW.Regulated expression of homeobox genes Msx-1 and Msx-2 in mouse mammary gland development suggests a role in hormone action and epithelial-stromal interactions. Dev Biol1996;
177:347–55
31.
OhnishiKSemiKYamamotoTShimizuMTanakaAMitsunagaKOkitaKOsafuneKAriokaYMaedaT.Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation. Cell2014;
156:663–77
32.
YamanakaS.A fresh look at iPS cells. Cell2009;
137:13–7
33.
WangXQOngkekoWMChenLYangZFLuPChenKKLopezJPPoonRTFanST.Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4–AKT–ATP‐binding cassette G2 pathway. Hepatology2010;
52:528–39
34.
GidekelSPizovGBergmanYPikarskyE.Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell2003;
4:361–70
35.
ChiouS-HWangM-LChouY-TChenC-JHongC-FHsiehW-JChangH-TChenY-SLinT-WHsuH-S.Coexpression of Oct4 and nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell–like properties and epithelial–mesenchymal transdifferentiation. Cancer Res2010;
70:10433–44
36.
MarazziGWangYSassoonD.Msx2 is a transcriptional regulator in the BMP4-mediated programmed cell death pathway. Dev Biol1997;
186:127–38
37.
TakahashiKNuckollsGHTanakaOSembaITakahashiIDashnerRShumLSlavkinHC.Adenovirus-mediated ectopic expression of Msx2 in even-numbered rhombomeres induces apoptotic elimination of cranial neural crest cells in ovo. Development1998;
125:1627–35
38.
HamadaSSatohKHirotaMKimuraKKannoAMasamuneAShimosegawaT.Bone morphogenetic protein 4 induces epithelial‐mesenchymal transition through MSX2 induction on pancreatic cancer cell line. J Cell Physiol2007;
213:768–74
39.
SatohKHamadaSKimuraKKannoAHirotaMUminoJFujibuchiWMasamuneATanakaNMiuraK.Up-regulation of MSX2 enhances the malignant phenotype and is associated with twist 1 expression in human pancreatic cancer cells. Am J Pathol2008;
172:926–39
40.
KeysarSBJimenoA.More than markers: biological significance of cancer stem cell-defining molecules. Mol Cancer Ther2010;
9:2450–7
41.
ZhangQShiSYenYBrownJTaJQLeAD.A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. Cancer Lett2010;
289:151–60
42.
HurtEMKawasakiBTKlarmannGJThomasSBFarrarWL.CD44+ CD24(−) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Br J Cancer2008;
98:756–65
43.
JaggupilliAElkordE.Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity. Clin Dev Immunol2012;
2012:708036
44.
SheridanCKishimotoHFuchsRKMehrotraSBhat-NakshatriPTurnerCHGouletRJrBadveSNakshatriH.CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res2006;
8:R59
